Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Sarcoma 1Osteosarcoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mobility Limitation 1COVID-19 1Breast Neoplasms 1

Interventions

Fulvestrant 25Letrozole 23Specimen Handling 19ribociclib 15Capecitabine 15pembrolizumab 14palbociclib 13abemaciclib 12Trastuzumab 12Paclitaxel 12exemestane 11Tamoxifen 11Magnetic Resonance Spectroscopy 11Anastrozole 11Carboplatin 10trastuzumab deruxtecan 8pertuzumab 8Biopsy 8Goserelin 7inavolisib 6Cyclophosphamide 6giredestrant 5Taxes 5Radiotherapy 5130-nm albumin-bound paclitaxel 5pyrotinib 4patritumab deruxtecan 4olaparib 4eribulin 4elacestrant 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Patient Reported Outcome Measures × 30 days × Clear all
NCT04769960 2026-05-18

Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

Memorial Sloan Kettering Cancer Center

Active not recruiting
68 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡